60 minutes. Could it be true?. Part one /
A look at the human test trials of SU5416, a new angiogenesis inhibitor, which shows promise as a cancer treatment. This is part one of a two-part segment. Ed Bradley reports.
Saved in:
| Other Authors: | , , |
|---|---|
| Format: | Electronic Video |
| Language: | English |
| Published: |
New York, NY :
Columbia Broadcasting System,
1999.
|
| Subjects: | |
| Online Access: |
Full text (Emmanuel users only) |